Companies / AbbVie Inc.
AbbVie Inc.
Financials · FY2025
Ownership
1.77B shares outstanding · as of Jul 27, 2026
Ownership
| Insiders | 0.05% | 901,124 |
| Institutions | 74.77% | 1,321,277,216 |
| Public float | 25.18% | 444,938,945 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 17
View all →| Insider | % of shares | Shares |
|---|---|---|
Saleki-Gerhardt AzitaEVP, CHIEF OPERATIONS OFFICER | 0.01% | 197,794 |
Michael Robert A.CEOCHAIRMAN OF THE BOARD AND CEO · Director | 0.01% | 178,737 |
Freyman Thomas CDirector | <0.01% | 127,869 |
Stewart Jeffrey RyanEVP, CHIEF COMMERCIAL OFFICER | <0.01% | 83,171 |
Donoghoe NicholasEVP, CHIEF BUS/STRAT OFFICER | <0.01% | 74,430 |
Thakkar RoopalEVP, R&D and CSO | <0.01% | 52,376 |
Rapp Edward JDirector | <0.01% | 45,964 |
Austin Roxanne SDirector | <0.01% | 39,576 |
Reents Scott TEVP, CHIEF FINANCIAL OFFICER | <0.01% | 38,777 |
Waddell Frederick HDirector | <0.01% | 30,076 |
Institutional holders 4,084
View all →| Holder | Value | % of shares |
|---|---|---|
| $41.31B | 10.23% | |
| $37.62B | 8.46% | |
| $20.78B | 4.67% | |
| $11.97B | 2.96% | |
| $10.14B | 2.64% | |
| $9.15B | 2.27% | |
| $5.90B | 1.46% | |
| $5.87B | 1.45% | |
| $5.81B | 1.44% | |
| $5.75B | 1.42% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Michael Robert A. CEO | Other | Common Stock, $0.01 par value | $8.48M | -37K -16.97% | 178,737 0.01% of shares | low |
| Feb 27, 2026 | Stewart Jeffrey Ryan Executive | Other | Common Stock, $0.01 par value | $5.53M | -24K -22.26% | 83,171 <0.01% of shares | low |
| Feb 25, 2026 | Siatis Perry C Executive | Sell | Common Stock, $0.01 par value | $5.15M | -22K -36.98% | 38,137 <0.01% of shares | medium |
| Feb 27, 2026 | Reents Scott T Executive | Other | Common Stock, $0.01 par value | $5.02M | -22K -35.82% | 38,777 <0.01% of shares | low |
| Feb 27, 2026 | Saleki-Gerhardt Azita Executive | Other | Common Stock, $0.01 par value | $3.78M | -16K -7.62% | 197,794 0.01% of shares | low |
| Feb 27, 2026 | Siatis Perry C Executive | Other | Common Stock, $0.01 par value | $3.45M | -15K -38.94% | 23,287 <0.01% of shares | low |
| Feb 27, 2026 | Donoghoe Nicholas Executive | Other | Common Stock, $0.01 par value | $2.99M | -13K -14.75% | 74,430 <0.01% of shares | low |
| Mar 2, 2026 | Siatis Perry C Executive | Sell | Common Stock, $0.01 par value | $2.41M | -10K -58.77% | 7,219 <0.01% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ABBV | — | 00287Y109 |